ArticleInflammatory bowel diseases2022

Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.

Scott David Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.